AXHIDROX 2.2mg / dose cream medication leaflet

D11AA01 glycopyrronium bromide • Dermatologicals | Other dermatological preparations | Antihidrotics

Glycopyrronium bromide is an anticholinergic medication primarily used for the treatment of obstructive respiratory diseases, such as chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors in the airways, leading to relaxation of bronchial smooth muscles and airway dilation, making breathing easier.

It is indicated for:

- Maintenance treatment of COPD to relieve symptoms such as shortness of breath.
- Reducing the frequency of disease exacerbations.

Glycopyrronium bromide is administered via an inhaler, usually once daily, as directed by a doctor.

Side effects may include dry mouth, throat irritation, cough, constipation, headache, or, rarely, allergic reactions. It is contraindicated in patients with hypersensitivity to glycopyrronium or other anticholinergics and should be used with caution in those with narrow-angle glaucoma, urinary retention, or other conditions that may be worsened by anticholinergic effects.

General data about AXHIDROX 2.2mg / dose

Substance: glycopyrronium bromide

Date of last drug list: 01-06-2023

Commercial code: W69551001

Concentration: 2.2mg / dose

Pharmaceutical form: cream

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL - GERMANIA

Holder: DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL - GERMANIA

Number: 14974/2023/01

Shelf life: 3 years-after packing for marketing;dupa prima actionare-12 months

Pharmaceutical forms available for glycopyrronium bromide

Concentrations available for glycopyrronium bromide

0.2mg/ml, 2.2mg/dose, 320mcg/ml, 44mcg